Pigment Epithelium Derived Factor Suppresses Expression of Sost/Sclerostin by Osteocytes: Implication for Its Role in Bone Matrix Mineralization

Osteoblast and osteocyte: Games without frontiers

(2014) Mattia Capulli et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Osteogenesis imperfecta due to mutations in non-collagenous genes

(2014) Joan C. Marini et al.   CURRENT OPINION IN PEDIATRICS

Regulation of Wnt/β-catenin signaling within and from osteocytes

(2013) Travis A. Burgers et al.   BONE

Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis

(2013) Maurizio Rossini et al.   CALCIFIED TISSUE INTERNATIONAL

Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content

(2013) Arijeet K. Gattu et al.   FASEB JOURNAL

A Mouse Model for Human Osteogenesis Imperfecta Type VI

(2013) Rosalind Bogan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Pigment Epithelium-Derived Factor Enhances Differentiation and Mineral Deposition of Human Mesenchymal Stem Cells

(2013) Feng Li et al.   STEM CELLS

Multipotent Mesenchymal Stem Cells from Human Subacromial Bursa: Potential for Cell Based Tendon Tissue Engineering

(2013) Na Song et al.   TISSUE ENGINEERING PART A

Effects of PTH on osteocyte function

(2012) Teresita Bellido et al.   BONE

Osteocalcin: Skeletal and extra-skeletal effects

(2012) Anna Neve et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling

(2012) Katherine A Staines et al.   JOURNAL OF ENDOCRINOLOGY

The skeleton as an endocrine organ

(2012) Douglas J. DiGirolamo et al.   Nature Reviews Rheumatology

Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin

(2012) N. Bonnet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exome Sequencing Identifies Truncating Mutations in Human SERPINF1 in Autosomal-Recessive Osteogenesis Imperfecta

(2011) Jutta Becker et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Mutations in SERPINF1 cause osteogenesis imperfecta type VI

(2011) Erica P Homan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism

(2011) Gerald J Atkins et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lack of expression ofSERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen

(2011) Giacomo Venturi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Identification of a Novel Inhibitor of the Canonical Wnt Pathway

(2011) K. Park et al.   MOLECULAR AND CELLULAR BIOLOGY

Sclerostin: Current Knowledge and Future Perspectives

(2010) M. J. C. Moester et al.   CALCIFIED TISSUE INTERNATIONAL

Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways

(2010) Carola Krause et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Different Forms of DMP1 Play Distinct Roles in Mineralization

(2010) A. Gericke et al.   JOURNAL OF DENTAL RESEARCH

Codon Preference Optimization Increases Heterologous PEDF Expression

(2010) Anzor G. Gvritishvili et al.   PLoS One

MEPE’s Diverse Effects on Mineralization

(2009) Adele L. Boskey et al.   CALCIFIED TISSUE INTERNATIONAL

Osteocytes, mechanosensing and Wnt signaling

(2008) Lynda F. Bonewald et al.   BONE

MEPE-ASARM Peptides Control Extracellular Matrix Mineralization by Binding to Hydroxyapatite: An Inhibition Regulated by PHEX Cleavage of ASARM

(2008) William N Addison et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Degradation of MEPE, DMP1, and Release of SIBLING ASARM-Peptides (Minhibins): ASARM-Peptide(s) Are Directly Responsible for Defective Mineralization in HYP

(2007) Aline Martin et al.   ENDOCRINOLOGY